FTDI
VIVO

First Trust Direct Indexing’s Meridian Bioscience Inc VIVO Stock Holding History

First Trust Direct Indexing’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-91
Closed -$2K – 1065
2020
Q4 		$2K Buy
+91
New +$1.7K ﹤0.01% 1113

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

First Trust Direct Indexing's VIVO Position: Q1 2021 in Review

First Trust Direct Indexing sold out of Meridian Bioscience Inc (VIVO) in Q1 2021, closing a stake of 91 shares — an estimated $2K sold.

First Trust Direct Indexing first reported a position in VIVO in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 215 funds tracked by Wall St. Rank hold VIVO as of Q1 2021.

  • First Trust Direct Indexing reported no remaining Meridian Bioscience Inc position as of Q1 2021 after selling out during the quarter.
  • First Trust Direct Indexing sold 91 Meridian Bioscience Inc shares in Q1 2021, an estimated $2K.
  • First Trust Direct Indexing first reported a position in Meridian Bioscience Inc in Q4 2020 and held it in 1 quarter.
  • First Trust Direct Indexing's Meridian Bioscience Inc position peaked at $2K in Q4 2020.
  • 215 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2021.

Based on First Trust Direct Indexing's 13F filing for Q1 2021, filed 14 Apr 2021.